Jiangxi Fushine Pharmaceutical Co (SZSE:300497) LT-Debt-to-Total-Asset : 0.14 (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Jiangxi Fushine Pharmaceutical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Jiangxi Fushine Pharmaceutical Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2025 was 0.14.

Jiangxi Fushine Pharmaceutical Co's long-term debt to total assets ratio declined from Mar. 2024 (0.21) to Mar. 2025 (0.14). It may suggest that Jiangxi Fushine Pharmaceutical Co is progressively becoming less dependent on debt to grow their business.

Jiangxi Fushine Pharmaceutical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Jiangxi Fushine Pharmaceutical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Fushine Pharmaceutical Co LT-Debt-to-Total-Asset Chart

Jiangxi Fushine Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.02

0.08

0.21

0.16

Jiangxi Fushine Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.21	0.16	0.16	0.16	0.14

Jiangxi Fushine Pharmaceutical Co LT-Debt-to-Total-Asset Calculation

Jiangxi Fushine Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	736.484	/	4536.876
	=	0.16

Jiangxi Fushine Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

LT Debt to Total Assets (Q: Mar. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2025 )	/	Total Assets (Q: Mar. 2025 )
	=	631.484	/	4523.479
	=	0.14

Jiangxi Fushine Pharmaceutical Co (SZSE:300497) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Jiangxi Fushine Pharmaceutical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Jiangxi Fushine Pharmaceutical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangxi Fushine Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.2 YULI Industrial Zone, Changjiang district, Jiangxi Province, Jingdezhen, CHN, 333000

Website

http://www.fushine.cn

Jiangxi Fushine Pharmaceutical Co Ltd is engaged in research and development, manufactures and sells APIs and pharmaceutical intermediates. It offers penicillin, carbapenem, and other products.

Executives

Liu Ying	Executives
Peng Yun	Secretary Dong
Zhang Xiang Ming	Executives
Wei Hai Peng	Executives
Bao Jian Hua	Directors, executives
Li Hui Yue	Director
Dai Zhen Liang	Executives
Yang Guang	Executives
Chen Ying Hui	Executives
Ke Dan	Director
Xu Chun Xia	Directors, executives
Yu Wen Jun	Director
Cheng Rong Wu	Directors, executives
Liu Zhi Min	Executives
Tang De Ping	Executives

Jiangxi Fushine Pharmaceutical Co Headlines

No Headlines